PNPLA3基因型与临床因素影响肝细胞癌风险:前瞻性队列研究结果
基于新加坡华人健康研究的前瞻性队列,纳入24979名参与者,中位随访19.8年确诊214例肝细胞癌。PNPLA3 I148M纯合男性携带者肝细胞癌风险为非携带女性的9.23倍,超重或糖尿病进一步增加风险,提示基因与临床因素联合可用于风险分层。
要点
- 男性PNPLA3 I148M纯合携带者肝细胞癌风险是非携带女性的9.23倍。
- 超重或糖尿病的纯合携带者肝细胞癌风险进一步升高约3倍。
- rs738409-G等位基因频率与肝细胞癌风险呈剂量依赖性增加。
核心结论
- rs738409-G等位基因频率与肝细胞癌风险呈剂量依赖性增加,且独立于其他临床风险因素。
- 在男性、超重和糖尿病患者中,携带rs738409-G等位基因者肝细胞癌风险进一步升高。
研究设计与样本
- 基于新加坡华人健康研究的大型、正在进行的、人群为基础的前瞻性队列研究。
- 纳入24979名参与者(54.2%女性),中位随访19.8年,确诊214例肝细胞癌。
主要发现
- 男性PNPLA3 I148M纯合携带者相比非携带女性肝细胞癌风险aHR=9.23(95%CI: 4.81-17.70)。
- 男性杂合携带者相比非携带女性肝细胞癌风险aHR=4.83(95%CI: 2.63-8.89)。
- 超重的纯合携带者相比非超重非携带者肝细胞癌风险aHR=2.92(95%CI: 1.74-4.89)。
- 糖尿病且纯合携带者相比无糖尿病非携带者肝细胞癌风险aHR=2.83(95%CI: 1.21-6.61)。
临床怎么用
- 可考虑将PNPLA3 I148M基因型与性别、超重、糖尿病等临床因素联合用于肝细胞癌风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: PNPLA3 variants are associated with increased hepatocellular carcinoma (HCC) risk. We examined the association between a combination of the PNPLA3 I148M genotype and clinical risk factors with HCC risk using data from a large, ongoing, population-based, prospective cohort study, the Singapore Chinese Health Study. APPROACH AND RESULTS: This study included 24,979 participants (54.2% female). The primary outcome was incident HCC. Fine-Grey models were used to examine the association between a combination of the PNPLA3 I148M genotype and clinical risk factors and risk of HCC. After a median follow-up of 19.8 years, we identified 214 HCC incident cases. Males who were homozygous carriers for PNPLA3 I148M (adjusted hazard ratio [aHR] = 9.23, 95% confidence interval [CI]: 4.81-17.70) had a nine-fold risk of HCC, while heterozygous male carriers (aHR 4.83, CI: 2.63-8.89) had a five-fold risk of HCC, compared to non-carrier females. Homozygous carriers who were overweight (aHR = 2.92, 95% CI: 1.74-4.89) had a three-fold risk of HCC compared to non-carriers who were not overweight. Participants with diabetes and who were homozygous carriers (aHR 2.83, 95% CI: 1.21-6.61) had an approximately three-fold risk of HCC compared to non-carriers without diabetes. CONCLUSION: The frequency of rs738409-G alleles was associated with a dose-dependent increase in HCC risk and was independent of other clinical risk factors. Among participants who were male, overweight, and those with diabetes, the risk of HCC was further elevated among those with rs738409-G alleles. These data may be helpful for the development of future risk stratification strategies.
引用
- Huang DQ, Zhang Z, Dorajoo R, et al. PNPLA3 Genotype and Clinical Factors Impact Hepatocellular Carcinoma Risk: Findings From a Prospective Cohort Study. Aliment Pharmacol Ther. 2026. PMID: 41527281. doi:10.1111/apt.70532
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。